Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

biocelect pty ltd - japanese encephalitis virus, quantity: 4 pfu - injection, powder for - excipient ingredients: albumin; mannitol; glutamic acid; histidine; sodium chloride; potassium hydroxide; lactose monohydrate; water for injections - imojev is indicated for prophylaxis of japanese encephalitis caused by the japanese encephalitis virus, in individuals from 9 months of age and over.

Filipíny - angličtina - FDA (Food And Drug Administration)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - japanese encephalitis virus (live, attenuated) - powder for suspension for injection (sc) - formulation: after reconstitution, one dose (0.5 ml) contains 4.0-5.8 log plaque forming units (pfu) live, attenuated, recombinant japanese encephalitis virus.

Singapur - angličtina - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - japanese encephalitis virus (live, attenuated, recombinant) - injection, powder, lyophilized, for suspension - 4.0-5.8 log pfu/dose - japanese encephalitis virus (live, attenuated, recombinant) 4.0-5.8 log pfu/dose

Filipíny - angličtina - FDA (Food And Drug Administration)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - japanese encephalitis vaccine (live, attenuated) - powder for suspension for injection (sc) - formulation: after reconstitution, one dose (0.5 ml) contains 4.0-5.8 log plaque forming units (pfu) live, attenuated, recombinant japanese encephalitis virus.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - japanese encephalitis virus, quantity: 6 agu - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate; water for injections - jespect is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect is indicated for persons who work with je virus in laboratories and in industry.

Malajzia - angličtina - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - live, attenuated, recombinant -

Európska únia - angličtina - EMA (European Medicines Agency)

valneva austria gmbh - japanese-encephalitis virus, inactivated (attenuated strain sa14-14-2 grown in vero cells) - encephalitis, japanese; immunization - vaccines - ixiaro is indicated for active immunisation against japanese encephalitis in adults, adolescents, children and infants aged two months and older.ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.

Filipíny - angličtina - FDA (Food And Drug Administration)

department of health - central office; distributor: department of health - central office - japanese encephalitis vaccine, live - freeze-dried injection in a vial - single dose of 0.5ml containing 5.4 lg pfu of live attenuated je virus

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - japanese encephalitis virus -

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - tick-borne encephalitis virus (inactivated) neudoerfl - suspension for injection in pre-filled syringe - 0.25 millilitre(s) - encephalitis vaccines; encephalitis, tick borne, inactivated, whole virus - encephalitis vaccines - it is indicated for the active (prophylactic) immunization of children aged from 1 year to 15 years against tick-borne encephalitis (tbe).